Lyra Therapeutics, Inc. (LYRA)
OTOTC · Common · CUSIP 55234L105
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for LYRA and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
55234L105
Market Cap
Small Cap
IPO
5/1/2020 · $16.00/share
Business: Lyra Therapeutics, Inc. is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat diseases.

Company Contact

CEO
Maria Palasis
CFO
Jason Cavalier
Headquarters
480 Arsenal Way, Watertown, MA 02472
Phone
617-393-4600
Investor Relations
Laurence Watts · 619-916-7620 · laurence@gilmartinir.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »